nasopharyngeal-carcinoma

Documents about nasopharyngeal-carcinoma

• Amifostine Plus Chemotherapy and Radiation Therapy in Treating Patients With Advanced, Unresectable Head and Neck Cancer#875322ClinicalTrials.gov
• Large-scale and high-resolution mass spectrometry-based proteomics defines molecular subtypes of nasopharyngeal carcinoma for therapeutic targeting.#308795NCBI PubMed Central
• CD70-targeted immunoPET Imaging of Malignant Cancers#847411ClinicalTrials.gov
• Combined multi-omics profiling and machine learning analysis reveals that Bregs and RPS2 promote bone metastasis in nasopharyngeal carcinoma.#685557NCBI PubMed Central
• The Prognostic Value of the Degree of Pathological Response of Induction Chemotherapy for NPC#912099ClinicalTrials.gov
• Developing personas for nutritional self-management in nasopharyngeal carcinoma patients: a qualitative study based on the Fogg Behavior Model.#975580NCBI PubMed Central
• Comparison of Oxycodone to Control Moderate or Severe Oral Mucositis Pain Induced by Chemoradiotherapy#980474ClinicalTrials.gov
• The Study to Evaluate Toripalimab (JS001) in Patients With Advanced GC, ESCC, NPC, HNSCC#862490ClinicalTrials.gov
• Association of neurite orientation dispersion and density imaging with cognitive impairment in nasopharyngeal carcinoma patients with radiation-induced temporal lobe injury.#285264NCBI PubMed Central
• Epstein-Barr virus-driven immunosuppression in nasopharyngeal carcinoma: a comprehensive review of viral mechanisms, spatial tumor ecosystems, and precision therapeutics.#334720NCBI PubMed Central
• Construction of a diagnostic model for nasopharyngeal carcinoma using a consensus machine learning approach and study of immune infiltration characteristics.#610323NCBI PubMed Central
• Efficacy and Safety of Celecoxib Combined with Gabapentin for Head and Facial Pain in Nasopharyngeal Carcinoma: A Retrospective Cohort Study.#613468NCBI PubMed Central
• Irinotecan Liposome Combined with S-1 in PD-1/L1 Inhibitor Refractory Recurrent or Metastatic NPC#802809ClinicalTrials.gov
• To Evaluate the Efficacy and Feasibility of Modified Reduce-volume Target IMRT in the Treatment of Patients With Non-metastatic NPC#873089ClinicalTrials.gov
• Hepatic Artery Infusion Pump for NPC Liver Metastases#904277ClinicalTrials.gov
• Using Massage of Maxillofacial and Oral Cavity to Prevent Radioactive Oral Mucositis#876057ClinicalTrials.gov
• Development and validation of a prediction model for moderate-to-severe radiation dermatitis in patients with nasopharyngeal carcinoma: A machine learning study.#67473NCBI PubMed Central
• Integrated bioinformatics and experimental validation identifies CLIC6 as a novel tumor suppressor regulating NF-κB signaling and immune microenvironment in nasopharyngeal carcinoma.#174538NCBI PubMed Central
• Prognostic value of the three-lineage cytopenia score in locally advanced nasopharyngeal carcinoma: A retrospective cohort study#453112PLOS
• Assessing Manual Acupuncture's Impact on Mucositis From Nasopharynx Cancer Radiotherapy: A Visual Analogue Scale (VAS) and Quality of Life Study#895332ClinicalTrials.gov
• Lovastatin and Pembrolizumab for the Treatment of Patients With Recurrent or Metastatic Head and Neck Cancer, LAPP Trial#873753ClinicalTrials.gov
• Building a prediction model for nasopharyngeal carcinoma based on machine learning using laboratory test indicators: A study targeting populations in high-risk areas#387640Europe PMC
• A Clinical-Radiomics Nomogram Based on Pretreatment Magnetic Resonance Imaging Predicting Tumor Residual at the End of Radiotherapy in Patients With Nasopharyngeal Carcinoma.#438953NCBI PubMed Central
• EPstein-barr Virus DNA Response to Systemic Therapy for Treatment Adaptation in High Risk NPC (EP-STAR)#839658ClinicalTrials.gov
• Development of a Classifier for Metabolic Subtypes of Nasopharyngeal Carcinoma to Guide Personalized Immunotherapy Strategies: Biomarker Analysis of the Phase III CONTINUUM and DIPPER Trials.#9069NCBI PubMed Central
• An Open-label, Multicentre, Phase II/III RCT of PFLL Versus GP Combined With JS001 as the First-line Therapy for mNPC#435745ClinicalTrials.gov
• Radiation Therapy With or Without Chemotherapy in Reducing Mouth Dryness in Patients With Nasopharyngeal Cancer#912914ClinicalTrials.gov
• Supplemental Material for: Isolated Brain Metastasis from Nasopharyngeal Carcinoma Six Years after the Initial Diagnosis: A Case Report and a Comprehensive Review of Relevant Literature#482269Figshare
• Determination of the financial burden borne by the healthcare provider in treating nasopharyngeal carcinoma (NPC) patient based on casemix system in Hospital Pakar Universiti Sains Malaysia (HPUSM)#673154USM Repository
• Under Whole-course of Immunotherapy, Gradient Fractionated RT with CCT Versus CFRT with CCT for LANPC Who Achieved PR Post Induction Chemotherapy.#880764ClinicalTrials.gov
• Baseline hemoglobin <11.0 g/dL has stronger prognostic value than anemia status in nasopharynx cancers treated with chemoradiotherapy#955594Koc University Digital Collections
• Cisplatin and Gemcitabine in Treating Patients With Advanced Squamous Cell Cancer of the Head and Neck#992083ClinicalTrials.gov
• Real-World RAIRI-Guided Risk Stratification for Adjuvant Therapy Benefit After Chemoradiotherapy in NPC#878859ClinicalTrials.gov
• Cisplatin Desensitization in a Patient with Nasopharyngeal Carcinoma Experiencing Urticarial Allergic to Cisplatin#930415Acta Interna: The Journal of Internal Medicine
• Examine the Prognostic Role of FLT PET/CT for Patients With LR-NPC Treated by Carbon Ion Therapy#1032338ClinicalTrials.gov
• the Study of Effect of Chronomodulated Chemotherapy on the Dendritic Cells Subsets in the Treatment of Advanced Nasopharyngeal Cancer#877487ClinicalTrials.gov
• A Head-to-head Comparison of [68Ga]Ga-FAPI and [68Ga]Ga-TATE PET/CT in Patients With Nasopharyngeal Carcinoma: a Single-center, Prospective Study#903471ClinicalTrials.gov
• Downregulation of SLC44A4 in nasopharyngeal carcinoma is associated with malignant progression, B-cell/TLS-related immune features, and sensitivity to DNA-damaging agents#316320PLOS
• Self-perceived burden and quality of life in patients with radiation-induced brain injury after radiotherapy for nasopharyngeal carcinoma: a cross-sectional study on the mediating role of stigma and the moderating role of sleep quality.#659730NCBI PubMed Central
• Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors#849329ClinicalTrials.gov